Portal implementation within anticoagulation care; amplification of selfmanagement.

Portal implementation within anticoagulation care; amplification of selfmanagement. - PORTALS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON43686

Enrollment

216

Registered

2013-01-31

Start date

2013-04-22

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloodlump thrombosis

Interventions

Participants who start with self-management will be randomly selected in a study group for face to face group training or in a study group for e-learning. Both groups will be trained in general know

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Under control for regular care by Saltro Thrombosis Service for at least the past 6 months Longterm anticoagulant therapy Stable clinical values for at least past 6 months Internet acces (with exception of control group)

Exclusion criteria

Exclusion criteria: Less than six months regular support by Saltro Thrombosis Service Shortterm indication for anticoagulant therapy Instable clinical values during last 6 months No internet acces (with exception of control group) Inability to complete questionnaires Severe terminal illness, substance abuse or immobility

Design outcomes

Primary

Measure	Time frame
Clinical effects: 1. blood clotting speed (INR) expressed as Time in Therapeutic Range (TTR) 2. number of thromboembolic events	—

Secondary

Measure	Time frame
Secondairy outcomes: 1. well being / quality of life 2. health care use 3. use of the portal Tertiairy outcomes 1. users' satisfaction 2. user profiles	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)